This filing is a routine conference participation announcement with no trading catalyst. Monitor the September 14 fireside chat for any updates on lacutamab, IPH4502, or financing progress, but do not trade on this filing alone. The critical event remains the company's ability to secure funding before the cash runway expires in Q3 2026.
Price Chart
Executive Summary
Innate Pharma filed a 6-K announcing participation in the H.C. Wainwright 28th Annual Global Investment Conference (Sept 14-16, 2026) with a fireside chat and one-on-one meetings. This is a routine investor relations event with no material financial or clinical data disclosed. The cross-filing context includes a prior 20-F (April 2026) that flagged a critical funding gap and going-concern risk, but this filing provides no update on financing, pipeline data, or cash runway, making it a non-event for trading purposes.
Key Facts
- Innate Pharma will present at H.C. Wainwright 28th Annual Global Investment Conference on September 14-16, 2026 in New York.
- Fireside chat scheduled for September 14, 2026 at 4:30 PM EDT.
- No new clinical data, financial results, or financing updates were disclosed in this filing.
- Prior 20-F (April 2026) highlighted a cash runway into Q3 2026 and a critical funding gap requiring non-dilutive financing or partnership.
Financial Impact
No financial figures disclosed in this filing.
Risk Factors
- No material information disclosed — stock may not react to this filing.
- Underlying going-concern risk from prior 20-F remains unaddressed.
- Conference participation may raise expectations for news that may not materialize.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 10 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (IPHA) — Batch item 1 | 0001628280-26-059963 |
| Document: a260902_6k.htm | 0001628280-26-059963 |
| Document: 0001628280-26-059963-index-headers.html | 0001628280-26-059963 |
| Document: 0001628280-26-059963-index.html | 0001628280-26-059963 |
| Document: 0001628280-26-059963.txt | 0001628280-26-059963 |
| 6-K Filing (IPHA) — Batch item 6 | 0001628280-26-059963 |
| Document: a260902_6k.htm | 0001628280-26-059963 |
| Document: 0001628280-26-059963-index-headers.html | 0001628280-26-059963 |
| Document: 0001628280-26-059963-index.html | 0001628280-26-059963 |
| Document: 0001628280-26-059963.txt | 0001628280-26-059963 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 27, 2026 today | 6-K | $1.54 | awaiting T+20 | — | $1.48 (−3.90%) |
Oct 21, 2026 6d ago | 6-K | $1.57 | awaiting T+20 | — | $1.48 (−5.73%) |
Oct 20, 2026 7d ago | 6-K | $1.58 | awaiting T+20 | — | $1.48 (−6.21%) |
Sep 17, 2026 5w ago | 6-K | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.48 (−22.51%) |
Sep 17, 2026 5w ago | 6-K | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.48 (−22.51%) |
Sep 17, 2026 5w ago | 6-K | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.48 (−22.51%) |
Sep 16, 2026 5w ago | Press Release | $1.91 $1.48 | ▼ −22.51% | ▼ −23.97% | $1.48 (−22.51%) |
Sep 10, 2026 6w ago | 6-K | $1.88 $1.48 | ▼ −21.28% | ▼ −23.40% | $1.48 (−21.28%) |
Sep 2, 2026 7w ago | 6-K | $2.17 $1.63 | ▼ −24.88% | ▼ −24.80% | $1.48 (−31.80%) |
Aug 14, 2026 10w ago | 6-K | $2.18 $1.85 | ▼ −15.14% | ▼ −13.15% | $1.48 (−32.11%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers